Friday, BioClinica announced a partnership with NextDocs, which is a global leader in providing life sciences organizations with Microsoft SharePoint-based compliance solutions - providing easier access to clinical trial information and decreasing the timeline for FDA submissions. Through their partnership, the two companies will offer integration that unites BioClinica's OnPoint Clinical Trial Management System (CTMS) with NextDocs' Electronic Trial Master Form (eTMF) products.
OnPoint CTMS empowers clinical trial sponsors and CROs to efficiently access, share, and analyze operational data through the power and ease of Microsoft SharePoint; eTMF gives customers a comprehensive document repository that streamlines essential trial documentation management and is Drug Information Association (NYSEARCA:DIA) reference model compliant. The joining of these two leading systems creates a highly flexible workflow that minimizes duplicate efforts and results in a seamless system for trial management and regulatory document routing. The two systems can also be deployed to the same SharePoint portal and sub-sites.
BioClinica and NextDocs are both Microsoft Gold-Certified partners. BioClinica has a longstanding reputation of industry-leading integration with Microsoft technology, providing study project managers with a comprehensive, real-time view into trial performance through the power of SharePoint and the Microsoft Office Suite. NextDocs is a worldwide leader in Microsoft SharePoint-based compliance solutions for life sciences organizations.
BioClinica's world leadership in providing integrated, technology-enhanced clinical trial management solutions spans two decades. The company supports pharmaceutical and medical device innovation with imaging core lab, Internet image transport, electronic data capture, interactive voice and Web response, clinical trial management, and clinical supply chain design and optimization solutions. BioClinica has had more than 2,000 successful trials to date. The company has supported the clinical development of many new medicines, from early phase trials through final approval, and has state-of-the-art, regulatory-body-compliant imaging core labs on two continents. BioClinica also supports eClinical and data management services across the globe from its offices in the U.S., Europe, and Asia.
For more information, visit the company's Web site at www.bioclinica.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html